论文部分内容阅读
手性药物国家工程中心是由国家发展改革委员会批准组建,依托中国科学院成都有机化学有限公司,以成都丽凯手性技术有限公司为法人的国家科技创新平台。主要承接中国科学院药学及化学制药的科技创新成果,进行高附加值的手性试剂、有机中间体、药物前体和原料药等技术的工程化开发和系统集成,为手性药物和中间体产业提供先进成熟的工艺和技术。同时,致力于各种化学药物杂质的合成、分离及结构鉴定,为药物质量研究提供支撑服务。成都丽凯手性技术有限公司成立于1997年,是中国科学院成都有机化学有限公司下属控股企业,是国内最
National Engineering Center for Chiral Drugs is approved by the National Development and Reform Commission set up, relying on the Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, Chengdu Li Kai Chiral Technology Co., Ltd. as a national legal science and technology innovation platform. Mainly to undertake the Chinese Academy of Sciences pharmacy and pharmaceutical science and technology innovation achievements, high value-added chiral reagents, organic intermediates, prodrugs and APIs and other technology engineering development and system integration for the chiral drugs and intermediates industry Provide advanced and mature technology and technology. At the same time, committed to a variety of chemical impurities in the synthesis, separation and structural identification, drug quality research to provide support services. Chengdu Li Kai Chiral Technology Co., Ltd. was established in 1997, the Chinese Academy of Sciences, Chengdu Organic Chemical Co., Ltd. under the holding company, is the most